These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22823398)

  • 1. Role of interleukin-6 in stress, sleep, and fatigue.
    Rohleder N; Aringer M; Boentert M
    Ann N Y Acad Sci; 2012 Jul; 1261():88-96. PubMed ID: 22823398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6: a cytokine and/or a major modulator of the response to somatic stress.
    Mastorakos G; Ilias I
    Ann N Y Acad Sci; 2006 Nov; 1088():373-81. PubMed ID: 17192581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis.
    Fragiadaki K; Tektonidou MG; Konsta M; Chrousos GP; Sfikakis PP
    J Rheumatol; 2012 Jan; 39(1):60-2. PubMed ID: 22133618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab.
    Atzeni F; Nucera V; Masala IF; Sarzi-Puttini P; Bonitta G
    Pharmacol Res; 2019 Nov; 149():104402. PubMed ID: 31536783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapeutic implication of IL-6 blockade.
    Tanaka T; Kishimoto T
    Immunotherapy; 2012 Jan; 4(1):87-105. PubMed ID: 22150003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue.
    Davis MC; Zautra AJ; Younger J; Motivala SJ; Attrep J; Irwin MR
    Brain Behav Immun; 2008 Jan; 22(1):24-32. PubMed ID: 17706915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimmunomodulation by nutrition in stress situations.
    Romeo J; Warnberg J; Gómez-Martínez S; Díaz LE; Marcos A
    Neuroimmunomodulation; 2008; 15(3):165-9. PubMed ID: 18781080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab, a humanized anti-IL-6R antibody, as an emerging therapeutic option for rheumatoid arthritis: molecular and cellular mechanistic insights.
    Hashizume M; Tan SL; Takano J; Ohsawa K; Hasada I; Hanasaki A; Ito I; Mihara M; Nishida K
    Int Rev Immunol; 2015 May; 34(3):265-79. PubMed ID: 25099958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 as a key player in systemic inflammation and joint destruction.
    Fonseca JE; Santos MJ; Canhão H; Choy E
    Autoimmun Rev; 2009 Jun; 8(7):538-42. PubMed ID: 19189867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids.
    Bower JE; Ganz PA; Aziz N; Olmstead R; Irwin MR; Cole SW
    Brain Behav Immun; 2007 Mar; 21(3):251-8. PubMed ID: 17008048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic uses of anti-interleukin-6 receptor antibody.
    Kang S; Tanaka T; Kishimoto T
    Int Immunol; 2015 Jan; 27(1):21-9. PubMed ID: 25142313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans.
    Brydon L; Walker C; Wawrzyniak A; Whitehead D; Okamura H; Yajima J; Tsuda A; Steptoe A
    Brain Behav Immun; 2009 Feb; 23(2):217-24. PubMed ID: 18835437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does stress affect the joints? Daily stressors, stress vulnerability, immune and HPA axis activity, and short-term disease and symptom fluctuations in rheumatoid arthritis.
    Evers AW; Verhoeven EW; van Middendorp H; Sweep FC; Kraaimaat FW; Donders AR; Eijsbouts AE; van Laarhoven AI; de Brouwer SJ; Wirken L; Radstake TR; van Riel PL
    Ann Rheum Dis; 2014 Sep; 73(9):1683-8. PubMed ID: 23838082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions.
    Mullington JM; Hinze-Selch D; Pollmächer T
    Ann N Y Acad Sci; 2001 Mar; 933():201-10. PubMed ID: 12000021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 subfamily cytokines and rheumatoid arthritis: role of antagonists.
    Jazayeri JA; Carroll GJ; Vernallis AB
    Int Immunopharmacol; 2010 Jan; 10(1):1-8. PubMed ID: 19804846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional communication between the brain and the immune system: implications for physiological sleep and disorders with disrupted sleep.
    Lorton D; Lubahn CL; Estus C; Millar BA; Carter JL; Wood CA; Bellinger DL
    Neuroimmunomodulation; 2006; 13(5-6):357-74. PubMed ID: 17709958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 knock-out mice show modified basal immune functions, but normal immune responses to stress.
    Manfredi B; Sacerdote P; Gaspani L; Poli V; Panerai AE
    Brain Behav Immun; 1998 Sep; 12(3):201-11. PubMed ID: 9769156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disrupted brain-immune system-joint communication during experimental arthritis.
    del Rey A; Wolff C; Wildmann J; Randolf A; Hahnel A; Besedovsky HO; Straub RH
    Arthritis Rheum; 2008 Oct; 58(10):3090-9. PubMed ID: 18821705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.
    Miller AH; Ancoli-Israel S; Bower JE; Capuron L; Irwin MR
    J Clin Oncol; 2008 Feb; 26(6):971-82. PubMed ID: 18281672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.